Recall: D-0654-2026

Class III - Minor Violations

Class IIIClassification

2026-06-01Initiated

OngoingStatus

SUN PHARMACEUTICAL INDUSTRIES Firm

Product

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Reason

Failed Impurities/Degradation Specifications

Distribution

U.S. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.